PFN1 and amyotrophic lateral sclerosis: Such abnormalities were observed at disease onset in patients, at early disease stages in mutant SOD1 ALS mouse models [52,53,68] and at the disease end-stage in transgenic G118V mutant PFN1 mice [22].